Intravenous Fluid Supplementation for Preterm Infants With Hyperbilirubinemia: A Retrospective Cohort Study

Heidi Al-Wassia1, Shadi Garrada

  • 1Department of Pediatrics, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia (Ms Al-Wassia); and Department of Pediatrics, King Fahad Specialist Hospital, Dammam, Saudi Arabia (Mr Garrada).

Insights

Fluid supplementation in preterm infants with jaundice (high bilirubin) speeds up bilirubin reduction and shortens phototherapy duration. This method is safe, showing no increase in prematurity-related complications.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Perinatology

Background:

  • Neonatal hyperbilirubinemia is a common issue, with phototherapy as the standard treatment.
  • Fluid supplementation is a potential strategy to lower serum bilirubin levels in newborns.

Purpose of the Study:

  • To evaluate the safety and efficacy of fluid supplementation versus standard fluid management in preterm infants with unconjugated hyperbilirubinemia undergoing phototherapy.

Main Methods:

  • A retrospective cohort study included preterm infants (28-32 weeks gestation) requiring phototherapy within the first week of life.
  • Data were collected from infants admitted to a neonatal intensive care unit in Jeddah, Saudi Arabia, during 2017.

Main Results:

  • Infants receiving fluid supplementation showed a significantly greater daily decline in total serum bilirubin and a shorter phototherapy duration.
  • No significant differences were observed in weight or sodium changes, or the need for exchange transfusion.
  • Prematurity-related in-hospital morbidities were comparable between the fluid supplementation and standard fluid management groups.

Conclusions:

  • Fluid supplementation in preterm infants undergoing phototherapy accelerates bilirubin reduction and reduces treatment duration without adverse effects on prematurity-related morbidities.
  • Further randomized controlled trials are recommended to confirm the benefits and risks of fluid supplementation in this population.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
75
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
8
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
360